Multaq

Multaq, only recently approved by the Food and Drug Administration (FDA) in July 2009, has been linked to liver damage in some patients, including two patients that have required the removal of their entire livers.  These patients had both been taking Multaq for under six months.

Multaq is a drug used to treat atrial flutter and fibrillation that could possibly lead to stroke.  The FDA will be adding a new warning for liver damage to the labeling of Multaq, which already has a black box warning for severe complications, including death, in people who have recently experienced serious heart problems.  If you or a loved one has experienced a severe liver complication while taking Multaq, contact The Law Offices of Larry H. Parker.  You may be entitled to compensation.

We Can Help

Our team of nationally recognized pharmaceutical litigation trial lawyers has helped thousands of clients successfully fight the big drug manufacturers.  We have successfully pursued lawsuits involving numerous dangerous drugs, including Vioxx®, fen-phen, and Ortho Evra® amongst many others.  Our record of success speaks for itself.

To schedule a FREE, confidential, no obligation consultation, contact us by email using our case submission form or by phone at (800) 333-0000.  If we don't get you any money, we won't charge you a dime.  The Law Offices of Larry H. Parker has offices in Long Beach, Los Angeles, Riverside, Bakersfield, and Fresno, California and Phoenix and Tucson, Arizona.

Multaq® is a registered trademark of Sanofi-Aventis.  All other trademarks are used solely for informational purposes.